BioWorld - Tuesday, April 28, 2026

BioWorld Science

Jan. 5, 2016

View Archived Issues

Arbutus initiates phase IIa study of ARB-001467 for chronic HBV

Read More

MedImmune initiates phase II trial of MEDI-6012 in coronary artery disease

Read More

Matinas BioPharma files IND application with FDA for MAT-2501

Read More

Fibrocell and Intrexon to address chronic inflammatory and degenerative diseases of the joint

Read More

Enrollment complete in phase I trial of AVXS-101 in spinal muscular atrophy type 1

Read More

Novel muscarinic receptor modulator demonstrates a positive profile in vivo and in vitro

Read More

Roche starts phase I trial of spinal muscular atrophy candidate RO-7034067

Read More

Merck KGaA, Pfizer and Syndax to evaluate avelumab and entinostat in ovarian cancer

Read More

Baxalta and Symphogen form immuno-oncology collaboration

Read More

Merck & Co. patents nAChR alpha7 PAMs

Read More

Yuma Therapeutics and The Brigham and Women's Hospital develop HSP90 inhibitors

Read More

Emulate develops Small Airway Lung-Chip

Read More

KineMed and Pfizer establish biomarker discovery collaboration

Read More

Additional gene variants identified for AMD

Read More

Yisheng Biopharma releases phase I topline results for PIKA rabies vaccine

Read More

Higher doses of laquinimod discontinued in two MS trials following cardiovascular events

Read More

Simoctocog alfa now available in U.S.

Read More

FDA grants priority review to Gilead's NDA for sofosbuvir/velpatasvir

Read More

Sprouty has an atypical role as an oncogene in colorectal cancer

Read More

University of Virginia's artificial pancreas technology to enter pivotal trials in type 1 diabetes

Read More

Panasonic Healthcare completes acquisition of Bayer AG's Diabetes Care business

Read More